Transgene expands myvac platform into non-small cell lung cancer with TG4070

BioArctic and Eli Lilly enter BrainTransporter collaboration with up to USD800m in milestone payments

Fusion Antibodies secures Canadian patent allowance for antibody library technology

Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB

Sanofi's Sarclisa SC formulation gains Japanese approval to treat multiple myeloma

Arletta Pharma Solutions names new chief medical officer

Kither Biotech completes Phase 1 KIT2014 clinical study

Novo Nordisk Foundation funds European initiative to accelerate drug discovery for cardiometabolic diseases

Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b

uniQure reports initial six‑month data from first AMT‑260 dose cohort

Incyte Japan wins approval for Minjuvi combination therapy in relapsed or refractory DLBCL

Teijin and Merz secure Japanese approval for additional XEOMIN indications

Alvotech raises USD165m in public offering and private placement

Oncoinvent reports recruitment milestone in Phase 2 study of Radspherin in ovarian cancer

Nortiva Bio launches to develop long-acting oral medicines using LYNX platform